On February 16, 2022 Amgen (NASDAQ:AMGN) reported that it has been named to Newsweek magazine’s list of "America’s Most Responsible Companies" for the third consecutive year; JUST Capital’s list of "America’s Most JUST Companies" for the fifth consecutive year; Barron’s list of "America’s Most Sustainable Companies" for the second consecutive year; and the Human Rights Campaign Foundation’s list of "Best Places to Work for LGBTQ+ Equality" for the sixth consecutive year (Press release, Amgen, FEB 16, 2022, View Source [SID1234608182]). These rankings reflect the company’s enduring commitment to environmental, social, and governance (ESG) issues.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

"Amgen’s mission is to serve patients and our ESG programs enable us to achieve that mission responsibly," said Judy Brown, senior vice president, Corporate Affairs at Amgen. "We will continue to do our part to build a better, healthier world by addressing the challenges facing society that matter most to our business and to our stakeholders."

Amgen’s four ESG pillars – Healthy People, Healthy Society, Healthy Planet, and a Healthy Amgen – include commitments to:

Achieve carbon neutrality by 2027, along with a 40% reduction in water used and a 75% reduction in waste disposed.1
Improve the diversity of its workforce as well as the diversity of patients participating in clinical trials of potential new Amgen medicines.
Provide employees with enhanced mental health support, including programs focused on communities of color, as well on the pandemic-related challenges facing parents.
Double its spend with diverse suppliers in the U.S. and triple its spend with Black-owned businesses by 2023.
Inspire the next generation of innovators through science education programs sponsored by the Amgen Foundation2 that reached over 24 million students worldwide last year.
Help those who are unable to afford the medicines they need through the Amgen Safety Net Foundation3, which has provided approximately $6 billion4 of our medicines at no cost over the past five years to qualifying patients in the United States.